Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma

BACKGROUND: Transarterial chemoembolization (TACE) is the standard treatment for hepatocellular carcinoma (HCC); the value of its combination with systemic therapy is worthy of further exploration. This study aimed to investigate the efficacy and safety of TACE combined with tyrosine kinase inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yue, Pan, Tao, Cai, Xi, He, Quan-Sheng, Zheng, Yu-Bao, Huang, Ming-Sheng, Jiang, Zai-Bo, Chen, Jun-Wei, Wu, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502547/
https://www.ncbi.nlm.nih.gov/pubmed/37720446
http://dx.doi.org/10.21037/jgo-23-486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502547/
https://www.ncbi.nlm.nih.gov/pubmed/37720446
http://dx.doi.org/10.21037/jgo-23-486

Ejemplares similares